HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gestational diabetes mellitus upsets the proportion of fatty acids in umbilical arterial but not venous plasma.

AbstractOBJECTIVE:
Neonates of women with gestational diabetes mellitus (GDM) have reduced levels of arachidonic acid (AA) (20:4 n-6) and docosahexaenoic acid (DHA) (22:6 n-3). To assess whether this is the result of impaired placental transfer or endogenous fetal metabolism, fatty acids in umbilical venous and arterial plasma were analyzed in neonates of GDM women.
RESEARCH DESIGN AND METHODS:
Fatty acids were analyzed by gas chromatography in the plasma of 15 subjects with GDM and 30 healthy control subjects undergoing elective cesarean section and in vein and artery cord blood collected separately.
RESULTS:
The percentages of AA (20:4 n-6), DHA (22:6 n-3), and total n-6 or n-3 polyunsaturated fatty acids (PUFAs) as well as total PUFAs were lower in umbilical arterial but not in venous plasma of neonates of the GDM versus the control group.
CONCLUSIONS:
An altered handling or metabolism of long-chain PUFAs by the fetus rather than impaired placental transfer seems to be responsible for the lower proportion of those fatty acids in the plasma of neonates of GDM mothers.
AuthorsHenar Ortega-Senovilla, Gioia Alvino, Emanuela Taricco, Irene Cetin, Emilio Herrera
JournalDiabetes care (Diabetes Care) Vol. 32 Issue 1 Pg. 120-2 (Jan 2009) ISSN: 1935-5548 [Electronic] United States
PMID18852337 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fatty Acids
  • Fatty Acids, Omega-6
Topics
  • Adult
  • Blood Glucose Self-Monitoring
  • Cesarean Section
  • Chromatography, Gas
  • Diabetes, Gestational (metabolism)
  • Fatty Acids (blood)
  • Fatty Acids, Omega-6 (blood)
  • Female
  • Humans
  • Pregnancy
  • Reference Values
  • Umbilical Arteries (metabolism)
  • Umbilical Veins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: